Does OMALIZUMAB Cause Post procedural infection? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Post procedural infection have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.
55
Reports of Post procedural infection with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
0
Deaths
39
Hospitalizations
How Dangerous Is Post procedural infection From OMALIZUMAB?
Of the 55 reports, 39 (70.9%) required hospitalization, and 12 (21.8%) were considered life-threatening.
Is Post procedural infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Post procedural infection?
ADALIMUMAB (1,109)
ETANERCEPT (362)
METHOTREXATE (226)
INFLIXIMAB (223)
UPADACITINIB (188)
TOFACITINIB (184)
GOLIMUMAB (177)
VEDOLIZUMAB (166)
RISANKIZUMAB-RZAA (157)
USTEKINUMAB (150)
Which OMALIZUMAB Alternatives Have Lower Post procedural infection Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS